Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia von Flynn, J, Jones, J, Johnson, A J, Andritsos, L, Maddocks, K, Jaglowski, S, Hessler, J, Grever, M R, Im, E, Zhou, H, Zhu, Y, Zhang, D, Small, K, Bannerji, R, Byrd, J C

Volltext

Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia von Rogers, K A, Ruppert, A S, Bingman, A, Andritsos, L A, Awan, F T, Blum, K A, Flynn, J M, Jaglowski, S M, Lozanski, G, Maddocks, K J, Byrd, J C, Woyach, J A, Jones, J A

Volltext

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells von Zhong, Y, El-Gamal, D, Dubovsky, J A, Beckwith, K A, Harrington, B K, Williams, K E, Goettl, V M, Jha, S, Mo, X, Jones, J A, Flynn, J M, Maddocks, K J, Andritsos, L A, McCauley, D, Shacham, S, Kauffman, M, Byrd, J C, Lapalombella, R

Volltext

The CD37-targeted antibody–drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model von Beckwith, K A, Frissora, F W, Stefanovski, M R, Towns, W H, Cheney, C, Mo, X, Deckert, J, Croce, C M, Flynn, J M, Andritsos, L A, Jones, J A, Maddocks, K J, Lozanski, G, Byrd, J C, Muthusamy, N

Volltext

Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy von Vasu, S, Wu, H, Satoskar, A, Puto, M, Roddy, J, Blum, W, Klisovic, R, Andritsos, L, Hofmeister, C, Benson, D M, Efebera, Y, Jaglowski, S, Penza, S, Cohen, D, Devine, S, Cataland, S

Volltext

The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma von Jaglowski, S M, Ruppert, A S, Hofmeister, C C, Elder, P, Blum, W, Klisovic, R, Vasu, S, Penza, S, Efebera, Y A, Benson, D M, Devine, S M, Andritsos, L A

Volltext

Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia von Alinari, L, Lapalombella, R, Andritsos, L, Baiocchi, R A, Lin, T S, Byrd, J C

Volltext

Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia von Mani, R, Mao, Y, Frissora, F W, Chiang, C-L, Wang, J, Zhao, Y, Wu, Y, Yu, B, Yan, R, Mo, X, Yu, L, Flynn, J, Jones, J, Andritsos, L, Baskar, S, Rader, C, Phelps, M A, Chen, C-S, Lee, R J, Byrd, J C, Lee, L J, Muthusamy, N

Volltext

An effective mobilization strategy for lymphoma patients after failed upfront mobilization with plerixafor von Haverkos, B M, McBride, A, O'Donnell, L, Scholl, D, Whittaker, B, Vasu, S, Penza, S, Andritsos, L A, Devine, S M, Jaglowski, S M

Volltext

Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma von Cohen, J B, Hall, N C, Ruppert, A S, Jones, J A, Porcu, P, Baiocchi, R, Christian, B A, Penza, S, Benson, D M, Flynn, J, Andritsos, L A, Devine, S M, Blum, K A

Volltext

A single center’s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation von Haverkos, B M, Huang, Y, Elder, P, O'Donnell, L, Scholl, D, Whittaker, B, Vasu, S, Penza, S, Andritsos, L A, Devine, S M, Jaglowski, S M

Volltext

Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center von Stephens, D M, Ruppert, A S, Jones, J A, Woyach, J, Maddocks, K, Jaglowski, S M, Andritsos, L A, Flynn, J M, Grever, M R, Lozanski, G, Johnson, A J, Muthusamy, N, Heerema, N A, Byrd, J C

Volltext

Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol von Blum, K A, Ruppert, A S, Woyach, J A, Jones, J A, Andritsos, L, Flynn, J M, Rovin, B, Villalona-Calero, M, Ji, J, Phelps, M, Johnson, A J, Grever, M R, Byrd, J C

Volltext

Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case–control study von Abandeh, F I, Lustberg, M, Devine, S, Elder, P, Andritsos, L, Martin, S I

Volltext

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response von Pierceall, W E, Warner, S L, Lena, R J, Doykan, C, Blake, N, Elashoff, M, Hoff, D V, Bearss, D J, Cardone, M H, Andritsos, L, Byrd, J C, Lanasa, M C, Grever, M R, Johnson, A J

Volltext

1414 The Impact Of COVID-19 On Individuals with Neck of Femur Fracture in The United Kingdom: A Systematic Review and Meta-analysis von Andritsos, L, Thomas, O, Pallikadavath, S, Sambhwani, S, Kirmani, S

Volltext

Osteointegration of hydroxyapatite-coated collars in cemented massive endoprostheses following revision surgery von Davies, Benjamin, Kaila, Rajiv, Andritsos, Loukas, Gray Stephens, Christian, Blunn, Gordon W., Gerrand, Craig, Gikas, Panagiotis, Johnston, Andrew

Volltext

Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective von Andritsos, Leslie A, Dunavin, Neil, Lozanski, Gerard, Jones, Jeffrey A, Blachly, James S, Lucas, David M, Byrd, John C, Kraut, Eric, Grever, Michael R

Volltext

A single center%apos;s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation von Haverkos, B M, Huang, Y, Elder, P, O'Donnell, L, Scholl, D, Whittaker, B, Vasu, S, Penza, S, Andritsos, L A, Devine, S M, Jaglowski, S M

Volltext

Ibrutinib. Inhibitor of tyrosine-protein kinase BTK, Oncolytic von Andritsos, L., Jaglowski, S.M.

Volltext